More than 2.5 million Dutch people suffer from chronic inflammatory skin disease, but it often takes a long time before the right treatment is found. That must change now.
This is the goal of the new research project for Next Generation Immunodermatology (NGID). This will investigate biomarkers of six common chronic skin diseases at the nanoscale. This is necessary to better understand the different forms of diseases, but also to be able later to test what current products do with these biomarkers. In this way, all kinds of data can finally be collected about what is best in any situation.
Will every patient soon have to hand over a slice of skin that goes through this whole process? new. It is also an intention to be able to make predictions with this data. Then it could look like this: Someone is reporting skin problems, the dermatologist has a tool with which they can measure the substances in that skin, and based on the models made using the data from the project, it’s possible to find out what kind of work the individual patient is doing. Better.
In addition to a large number of researchers, the patients themselves are closely involved in the six-year project. Attention is also paid to the psychological aspect (what is the preference of the person visiting the doctor) and at the same time all kinds of research are carried out in the clinic on existing patients in order to reach the best possible data set.
In this audio you can hear Ellen van den Bogaard of Radboud UMC, Rob Vreeken of Maastricht University and Robert Rissmann of Leiden University.
Read more about this project here: UM coordinates the first national study on dermatology†
“Travel enthusiast. Alcohol lover. Friendly entrepreneur. Coffeeaholic. Award-winning writer.”